alexa Triple-negative breast cancer.
Immunology

Immunology

Immunotherapy: Open Access

Author(s): Foulkes WD, Smith IE, ReisFilho JS, Foulkes WD, Smith IE, ReisFilho JS, Foulkes WD, Smith IE, ReisFilho JS, Foulkes WD, Smith IE, ReisFilho JS

Abstract Share this page

Abstract Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment. This article was published in N Engl J Med and referenced in Immunotherapy: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords